TY - JOUR
KW - Disease Progression
KW - France/epidemiology
KW - Humans
KW - Patient Acceptance of Health Care
KW - *Pulmonary Disease, Chronic Obstructive/epidemiology/therapy
KW - United Kingdom/epidemiology
KW - COPD epidemiology
AU - H. Whittaker
AU - E. Van Ganse
AU - F. Dalon
AU - M. Nolin
AU - C. Marrant-Micallef
AU - C. Pison
AU - D. Ryan
AU - G. Deslee
AU - J. Quint
AU - M. Belhassen
AD - National Heart and Lung Institute, Imperial College London, London, UK h.whittaker@imperial.ac.uk.
PELyon, Pharmaco Epidemiologie Lyon, Lyon, France.
Respiratory Medicine, Hospital Croix-Rousse, Lyon, France.
Clinique de Pneumologie, Centre Hospitalier Universitaire de Grenoble, Service de Pneumologie, Grenoble, France.
Allergy and Respiratory Research Group, Centre for Population Health Sciences: GP Section, University of Edinburgh, Edinburgh, UK.
Department of Respiratory Medicine, INSERM UMRS 903, University Hospital of Reims, Reims, France.
National Heart and Lung Institute, Imperial College London, London, UK.
AN - 35944943
BT - BMJ Open Respir Res
C2 - PMC9367183
DO - 10.1136/bmjresp-2021-001150
DP - NLM
ET - 2022/08/10
LA - eng
M1 - 1
N1 - 2052-4439
Whittaker, Hannah
Van Ganse, Eric
Dalon, Faustine
Nolin, Maeva
Marrant-Micallef, Claire
Pison, Christophe
Ryan, Dermot P
Deslee, Gaetan
Quint, Jennifer K
Belhassen, Manon
Journal Article
BMJ Open Respir Res. 2022 Aug;9(1):e001150. doi: 10.1136/bmjresp-2021-001150.
PY - 2022
SN - 2052-4439
T2 - BMJ Open Respir Res
TI - Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France
VL - 9
ER -